Their data revealed that while galectin-7 transcripts were expressed at low levels in normal breast tissues and mammary epithelial cell lines, they were highly expressed in estrogen receptor (ER)-negative breast cancer and in cell lines with a basal-like phenotype. This evidence concerns the gene LGALS7 and breast carcinoma.